Physician profile
Ashley A Guy
NPI 1851615876
$4,925.02
in general payments reported to CMS, 2019-2025
40 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,162 · 2020: $558 · 2021: $616 · 2022: $642 · 2023: $793 · 2024: $687 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,947.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,309.06 | 2019-2025 | |
| Lilly USA, LLC | $441.98 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals Lp | $336.27 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $294.99 | 2019-2024 | Otezla, Repatha |
| Corium, LLC | $261.88 | 2022-2025 | Azstarys |
| Novo Nordisk INC | $245.36 | 2019-2025 | Wegovy, Saxenda |
| Pfizer INC. | $228.78 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $198.89 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Glaxosmithkline, LLC. | $147.64 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Kowa Pharmaceuticals America, INC. | $129.19 | 2019-2022 | |
| Amarin Pharma, INC. | $125.44 | 2019-2020 | |
| Astellas Pharma US INC | $110.67 | 2019-2023 | Veozah, Myrbetriq |
| Allergan, INC. | $95.74 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $92.64 | 2020-2024 | Trintellix |
| Exact Sciences Corporation | $89.83 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Guy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.